NDC 17856-1124-01 - Metamucil Therapy for regularity
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1124
- Requested NDC
- 17856-1124-01
- Package NDCs from labels
- 17856-1124-1, 17856-1124-2, 17856-1124-01
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2026-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metamucil Therapy for regularity - Atlantic Biologicals Corp. | Atlantic Biologicals Corp. | 2026-08-05 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Citrate | LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON | CARDINAL HEALTH, INC. 063997360 | 10bdd5e6-3db2-8f9e-e063-6394a90a9b3f | 2024-02-06 | Warnings | M007 |
| Magnesium Citrate | LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | CARDINAL HEALTH, INC. 063997360 | 10beb3ec-a189-221d-e063-6394a90aabb5 | 2024-02-06 | Warnings | M007 |
| Magnesium Citrate | LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | CARDINAL HEALTH, INC. 063997360 | 10bebb63-19b3-2e14-e063-6394a90a8d4e | 2024-02-06 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Proficient Rx LP | f9ac0344-5864-4ac1-81bc-16878a5946c5 | 2024-02-01 | Warnings | M007 |
| Purifi Hand Sanitizer | BENZALKONIUM CHLORIDE | Purifi LLC | 9267069d-4cf5-4e48-a446-7dbebea16bf5 | 2024-01-31 | Warnings | M007 |
| WOMENS LAXATIVE ENTERIC COATED | BISACODYL | CARDINAL HEALTH | ab34bc89-6738-d284-e053-2a95a90a5dc9 | 2024-01-11 | Warnings | M007 |
| MAXIMUM STRENGTH LAXATIVE | SENNOSIDES | CARDINAL HEALTH | b7b13bfa-8a94-6f62-e053-2995a90abbf4 | 2024-01-10 | Warnings | M007 |
| FIBER LAXATIVE | CALCIUM POLYCARBOPHIL | Magno-Humphries, Inc. | e4a921c5-1cf7-12ca-e053-2a95a90a6e04 | 2024-01-03 | Warnings | M007 |
| Freskaro Castor Oil | CASTOR OIL | Pharma Nobis, LLC | fbd6bdd5-a7a1-3f28-e053-6294a90aab87 | 2023-12-28 | Warnings | M007 |
| Humco Castor Oil | CASTOR OIL | Pharma Nobis, LLC | e42f9d37-1b07-177a-e053-2a95a90a9b06 | 2023-12-26 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Pharma Nobis, LLC | f0477328-eca1-9043-e053-2995a90aaa3d | 2023-12-22 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Pharma Nobis, LLC | f0489f6f-9e60-7d69-e053-2a95a90a9dfb | 2023-12-22 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Pharma Nobis, LLC | f0488c86-6c74-3987-e053-2a95a90a31b4 | 2023-12-22 | Warnings | M007 |
| Mineral Oil Heavy | MINERAL OIL | Pharma Nobis, LLC | e42f6c6d-c4de-02c6-e053-2995a90a3ace | 2023-12-22 | Warnings | M007 |
| Quality Choice Castor Oil | CASTOR OIL | Chain Drug Market Asociation | 18d7124f-7745-45b2-adc4-cb1103add5d6 | 2023-12-20 | Warnings | M007 |
| Premiere Value Castor Oil | CASTOR OIL | Chain Drug Consortium | 5c8c1564-fcff-894b-e053-2991aa0a9c0b | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Bionpharma, Inc. | f0fa4b72-50a5-5c42-e053-2995a90a159a | 2023-12-20 | Warnings | M007 |
| Harris Teeter Castor Oil | CASTOR OIL | Harris Teeter, LLC | 5cca6b4b-d88f-1c7d-e053-2991aa0a051f | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Bionpharma, Inc. | f0f9c36e-c43b-05d2-e053-2995a90a6d65 | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Bionpharma, Inc. | f0f9ff19-ae08-0af0-e053-2a95a90ab842 | 2023-12-20 | Warnings | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.